| |
|
|
|
Keystone Symposia, Whistler, British Columbia, Canada
March 25 - 30, 2007
Recent research has highlighted the dynamic nature of the ongoing conflict between HIV and its infected host; if left untreated, this is a battle that is almost always won by the virus. Much progress has been made in understanding critical host-pathogen interactions at the molecular and cellular levels. For instance, viral and cellular determinants of transmission have been defined, new mechanisms of innate anti-HIV resistance discovered, key differences between pathogenic and non-pathogenic HIV/SIV infections identified, immunopathogenic consequences of HIV infection elucidated and three-dimensional structures of critical cellular and viral proteins (and RNAs) deduced. Major future challenges for HIV/AIDS researchers include not only incorporating this information into models of HIV pathogenesis, but also defining logical new therapeutic targets and providing rational perspectives to vaccine design. By bringing together international leaders in research, new and exciting findings in these areas will be discussed, emerging concepts debated and new paradigms established. Finally, by including “abstract-driven workshops” in our program, less-senior investigators and trainees will get the opportunity to showcase their talents and contribute to the appeal and success of the meeting.
|
|
|
|
|
|
|
|
Organized by:
|
|
Michael H. Malim, Julie M. Overbaugh and Robert W. Doms |
|
|
Invited Speakers:
|
|
- Charles Bangham, Imperial College School of Medicine
- Mary Carrington, National Cancer Institute, National Institutes of Health
- Jim Champoux, University of Washington
- Bryan Cullen, Duke University Medical Center
- Anthony Cunningham, Westmead Millennium Institute
- Cynthia Derdeyn, Emory University
- Robert Doms, University of Pennsylvania School of Medicine
- Alan Engelman, Dana Farber Cancer Institute
- Warner Greene, Gladstone Institute of Virology and Immunology
- Stephen Harrison, Harvard Medical School
- Thomas Hope, Northwestern University
- Katherine Jones, The Salk Institute
- Richard Koup, National Institutes of Health
- Daniel Kuritzkes, Brigham and Women's Hospital, Harvard Medical School
- Celia LaBranche, GlaxoSmithKline
- Harmit Malik, Fred Hutchinson Cancer Research Center
- Michael Malim, King's College London School of Medicine
- Dorothy Mbori-Ngacha, University of Nairobi
- John Moore, Weill Medical College of Cornell University
- John Moran, University of Michigan Medical School
- Julie Overbaugh, Fred Hutchinson Cancer Research Center
- Douglas Richman, University of California, San Diego
- Guido Silvestri, Emory University
- Paul Spearman, Emory University
- Wesley Sundquist, University of Utah School of Medicine
- Greg Towers, University College London
- Alexandra Trkola, University Hospital Zurich
- Didier Trono, University of Geneva
- Bruce Walker, Massachusetts General Hospital
- Ian Wilson, The Scripps Research Institute
- Steven Wolinsky, Northwestern University
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Nov. 27, 2006
|
|
|
|
|
|
|
|
Registration:
|
|
Please see website
|
|
|
E-mail:
|
|
info@keystonesymposia.org
|
|
|
|
|
|
|
|
|